As of 2026-09-15, the Relative Valuation of Biogen Inc (BIIB) is 209.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 217.36 USD, the upside of Biogen Inc based on Relative Valuation is -3.6%.
The range of the Relative Valuation is 169.69 - 282.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.0x - 36.9x | 30.6x |
| Forward P/E multiples | 25.0x - 29.6x | 25.8x |
| Fair Price | 169.69 - 282.96 | 209.58 |
| Upside | -21.9% - 30.2% | -3.6% |
| Date | P/E |
| 2026-09-14 | 38.48 |
| 2026-09-11 | 38.44 |
| 2026-09-10 | 38.14 |
| 2026-09-09 | 37.31 |
| 2026-09-08 | 37.62 |
| 2026-09-04 | 39.09 |
| 2026-09-03 | 39.75 |
| 2026-09-02 | 39.42 |
| 2026-09-01 | 38.25 |
| 2026-08-31 | 38.35 |
| 2026-08-28 | 38.68 |
| 2026-08-27 | 39.21 |
| 2026-08-26 | 39.14 |
| 2026-08-25 | 39.08 |
| 2026-08-24 | 38.61 |
| 2026-08-21 | 38.38 |
| 2026-08-20 | 37.95 |
| 2026-08-19 | 39.22 |
| 2026-08-18 | 37.63 |
| 2026-08-17 | 37.03 |
| 2026-08-14 | 37.15 |
| 2026-08-13 | 37.29 |
| 2026-08-12 | 36.98 |
| 2026-08-11 | 36.09 |
| 2026-08-10 | 36.67 |
| 2026-08-07 | 36.81 |
| 2026-08-06 | 36.52 |
| 2026-08-05 | 36.58 |
| 2026-08-04 | 36.90 |
| 2026-08-03 | 35.73 |
| 2026-07-31 | 35.93 |
| 2026-07-30 | 36.81 |
| 2026-07-29 | 37.04 |
| 2026-07-28 | 36.40 |
| 2026-07-27 | 35.43 |
| 2026-07-24 | 35.79 |
| 2026-07-23 | 35.52 |
| 2026-07-22 | 35.01 |
| 2026-07-21 | 35.97 |
| 2026-07-20 | 35.40 |
| 2026-07-17 | 36.47 |
| 2026-07-16 | 36.99 |
| 2026-07-15 | 34.92 |
| 2026-07-14 | 33.98 |
| 2026-07-13 | 37.00 |
| 2026-07-10 | 35.26 |
| 2026-07-09 | 35.21 |
| 2026-07-08 | 35.47 |
| 2026-07-07 | 36.42 |
| 2026-07-06 | 36.90 |